← All Surmodics INC filings

Surmodics INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

SRDX
Surmodics INC
10-K: Surmodics Reports Fiscal 2024 Results Amidst Pending Merger, Faces Revenue Headwinds in 2025
Surmodics' fiscal year 2024 saw a revenue decrease and a net loss, with the company anticipating further revenue declines in 2025 due to reduced SurVeil DCB sales, all while navigating a pending merger.